Swedish Cancer Institute Revenue and Competitors
Estimated Revenue & Valuation
- Swedish Cancer Institute's estimated annual revenue is currently $70.4M per year.
- Swedish Cancer Institute's estimated revenue per employee is $297,000
Employee Data
- Swedish Cancer Institute has 237 Employees.
- Swedish Cancer Institute grew their employee count by 0% last year.
Swedish Cancer Institute's People
Name | Title | Email/Phone |
---|
Swedish Cancer Institute Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $8.4M | 39 | 5% | N/A | N/A |
#2 | $8.9M | 41 | 3% | N/A | N/A |
#3 | $5.3M | 28 | -18% | N/A | N/A |
#4 | $14.1M | 58 | 16% | N/A | N/A |
#5 | $75.4M | 254 | 2% | N/A | N/A |
#6 | $80.8M | 272 | 15% | N/A | N/A |
#7 | $26.5M | 98 | 9% | N/A | N/A |
#8 | $35.9M | 103 | 16% | N/A | N/A |
#9 | $49.3M | 166 | 12% | N/A | N/A |
#10 | $44M | 148 | 30% | N/A | N/A |
What Is Swedish Cancer Institute?
As a leader in cancer diagnosis and treatment since 1932, the Swedish Cancer Institute team offers the best available technology and procedures for treating cancer patients.
keywords:N/AN/A
Total Funding
237
Number of Employees
$70.4M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Swedish Cancer Institute News
2022-04-20 - Genentech-led team uncovers how cancer cells resist T cell attack in ... Fierce Biotech
Genentech-led team uncovers how cancer cells resist T cell attack in ... Fierce Biotech
2022-04-06 - 30 Under 35 | Next question: Jolyn Hull | 30under35 ... Wenatchee World
30 Under 35 | Next question: Jolyn Hull | 30under35 ... Wenatchee World
2022-03-22 - Obituary | Nena C Roman Harvey Family Funeral Home
Obituary | Nena C Roman Harvey Family Funeral Home
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $36M | 239 | 3% | $18M |
#2 | $39.4M | 239 | -13% | N/A |
#3 | $53.9M | 239 | 6% | N/A |
#4 | $65.7M | 239 | 20% | N/A |
#5 | $15M | 239 | 2% | N/A |